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Abstract 
BACKGROUND: HIV, which causes AIDS, infects the immune system cells, by destroying or damaging the 
function of the CD4. PLWHA will have twice the risk of experiencing mental health disorders such as depression 
and anxiety compared with the general population, thereby suppressing immune function, decreasing their quality 
of life, decreasing the level of adherence to treatment, and contributing significantly to the occurrence of 
premature death.  
AIM: To determine the correlation Anxiety and Depression symptoms and CD4 levels in PLWHA who are 
undergoing Anti-Retroviral treatment at the HIV/AIDS  
METHODS: The study was a cross-sectional study, which assesses the correlation between Hospital Anxiety and 
Depression Scale scores (HADS) and CD4 levels in PLWHA who are receiving ARV in the HIV/AIDS Special 
Services Polyclinic Medan Haji general hospital. 
RESULTS: It was found that the average HADS-A score, PLWHA was 15.286 and the SD ± 2.244. This shows 
that PLWHA is in moderate to severe anxiety and moderate to severe depression. The mean CD4 level of people 
with HIV/AIDS/PLWHA was 288.171 and SD ± 88.955. According to WHO criteria, regarding the classification of 
HIV immunodeficiency in adults, are classified as moderate immunodeficiency. There was a significant correlation 
between the HADS-A score and CD4 level with a correlation value of r = -0.592 indicating a negative correlation 
with a moderate correlation strength, and the correlation between HADS-D score and CD4 level. The strength of 
the relationship between HADS-D score and CD4 level is r = -0.650, shows a negative correlation with strong 
correlation strength. 
CONCLUSION: from this study, it was found that there is a relationship between depression and anxiety symptom 
and CD4 level. 
 
 
 
 
 
 
Introduction 
 
Human Immunodeficiency Virus/HIV, infects 
the immune system cells, by destroying or damaging 
the function of the Cluster of Differentiation 4/CD4. 
This viral infection results in a progressive 
deterioration of the immune system, which causes 
immune deficiency. Infections associated with severe 
immunodeficiency are known as opportunistic 
infections because this virus utilises a weakened 
immune system [1]. AIDS is a set of symptoms of a 
disease caused by decreased immunity which results 
in a person susceptible to opportunistic infections and 
tumours [1]. HIV diagnosis is confirmed by 
examination laboratory, and always preceded by pre-
test counselling or brief information. Laboratory tests 
carried out by antibody tests using stratification III 
(examination using 3 types of antibody tests with 
different sensitivity and specificity) [2], [3]. 
Mental disorders play several roles in the 
epidemiology of HIV, both in treatment elements and 
in comorbidities. Psychiatric conditions are associated 
with increased risky behaviour for infection, with 
reduced access to health services, with a decrease in 
adherence to HIV therapy, and with an increase in 
medical disorders and comorbidity. Individuals with 
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various types of mental illness that are not treated are 
susceptible to an increase in the frequency of unsafe 
sex and thus increase the risk of HIV infection [4]. 
PLWHA will have twice the risk of experiencing mental 
health disorders such as depression and anxiety 
compared with the general population, thereby 
suppressing immune function, decreasing their quality 
of life, decreasing the level of adherence to treatment, 
and contributing significantly to the occurrence of 
premature death. 
CD4 counts can be used to monitor the 
progress of severe infections and to see the immune 
system, determine when to start antiretroviral therapy 
and to monitor the progress of treatment. The body's 
initial immune response to HIV, the CD4 count, will 
return to normal levels, then it will decrease. About 
100 CD4 cells per year on average will decrease 
which is then followed by a decrease in the patient's 
clinical condition [2], [3]. 
Table 1: HIV immunodeficiency classifications in adults using 
CD4 according to WHO [3] 
Immunodeficiency CD4 count (cell/mm
3
) 
There are no > 500 
Lightweight 350−499 
Moderate 200−349 
Weight < 200 or < 15 % 
Excerpted from: Ministry of Health of the Republic of Indonesia in 2015. Regulation of the 
Minister of Health of the Republic of Indonesia Number 87 of 2014 concerning Guidelines 
for Anti Retro Viral Treatment. 2014:25. 
 
According to Mini ICD-10, depression is an 
mood that has the main symptoms of a depressive 
mood, loss of interest and excitement and reduced 
energy leading to increased fatigue and reduced 
activity, as well as several other symptoms such as 
reduced concentration and attention, price self and 
self-confidence diminish, ideas of guilt and 
uselessness, gloomy future views, ideas or actions 
that endanger themselves or suicide, disturbed sleep 
and reduced appetite [5]. Depression is the most 
common neuropsychiatric complication in infected 
patients HIV/AIDS [6], [7]. In the meta-analysis carried 
out by Cielsa and Robert, PLHIVs had a two-fold 
increased risk of developing depression compared 
with the negative control. 
Depression in people infected with HIV may 
be related to neurobiological changes caused by the 
invasion of HIV in the central nervous system. Guerra 
et al., Provide an understanding of the comprehensive 
relationship between the role of neuroendocrine, 
immune-inflammatory and monoaminergic 
mechanisms for the occurrence of depression in HIV. 
These interrelated mechanisms are caused directly by 
the virus and indirectly by psychological stress 
associated with the psychosocial impact of HIV 
diagnosis, can induce the activity of the hypothalamus 
Pituitary Adrenal (HPA) axis and the sympathetic 
autonomic nervous system which activates immune 
cells both peripherally and in the central nervous 
system. From this mechanism there is the release of 
tumor necrosis factors alpha (TNF-α), s interferon-
gamma (INF-γ), interleukin-1 (IL-1) and interleukin-6 
(IL-6), which ultimately causes PLWHA to occur 
"behaviour a state of chronic illness", characterized by 
weakness, reduced appetite, lethargy, psychomotor 
retardation, anhedonia, and changes in mood and 
cognitive moods.  
Glycoprotein 120 and Tat protein can activate 
brain glial cells. Proinflammatory cytokines can 
actively become tryptophan degrading enzymes that 
will reduce the bioavailability of tryptophan, affect the 
brain serotoninergic neurotransmission and lead to 
symptoms of depression [8]. 
Comprehensive anxiety disorder is defined as 
excessive anxiety and worries about several events or 
activities throughout the day for at least one 6-month 
period. Worrying is difficult to control and is 
associated with somatic symptoms, such as muscle 
tension, irritability, difficulty sleeping, and anxiety. 
Anxiety is difficult to control, subjectively troublesome 
and results in a decrease in an important area of one's 
life [9]. 
The results of existing studies indicate that 
genetics may play a role in anxiety disorders. Single 
nucleotide polymorphism (SNP) in brain-derived 
neurotrophic factor (BDNF) plays a role in fear 
response as in animal studies. Individuals who have a 
history of first-degree families who suffer from anxiety 
disorders are more at risk of suffering from anxiety 
disorders than the general population. Individuals born 
with lower transporters have a higher risk of anxiety 
disorders [10]. Neurotransmitters that play a role in 
anxiety disorders are norepinephrine, serotonin, and 
gamma-aminobutyric acid [11], [12].
 
Depression and 
anxiety are very important psychopathological 
comorbidities in patients with HIV/AIDS [13].
 
 
 
Methods 
 
Subjects and Procedure 
This is a cross-sectional study approach that 
is describing and analysing a situation in a given 
moment, which assesses the correlation between 
HADS and CD4 levels in PLWHA who are currently 
receiving ARV therapy at the HIV/AIDS Special 
Services Polyclinic Medan Haji general hospital. 
Inclusion criteria, namely participants are people with 
stage II and III HIV/AIDS based on WHO criteria, aged 
25-49 years, long diagnosed < 4 years, had received 
line I ARV therapy > 6 months, are willing as 
respondents and could be interviewed, last education 
was minimal graduated from junior high school or 
equivalent. Exclusion criteria are suffering from other 
psychiatric diseases before being diagnosed with 
HIV/AIDS, a history of the use of alcohol and 
prohibited substances. 
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Measurements 
Before further analysis of the demographic 
characteristics of age, education, marital status, 
duration of diagnosis, occupational status must be 
tested for normality. Variables with a numerical scale 
are expressed in mean and standard deviations. 
HADS consists of 14 questions consisting of two 
subscales, namely anxiety (7 questions) and 
depression (7 questions). Each question is measured 
by 4 scale value, from a value of 0 (not at all) to a 
value of 3 (very often) [11], [12], [13]. Higher values 
indicate the existence of a problem. Answers are 
summed separately, i.e. assessments for anxiety and 
assessment for depression, with minimum and 
maximum amounts of 0 and 21 for each scale [11], 
[12], [15]. Recommended values are: 16-21 severe 
state cases, 11-15 values are cases moderate, grades 
8-10 state mild cases, and less than 7 are not cases 
of anxiety or depression [1], [12], [14], [15]. 
 
Data Analysis 
Data was analysed by using SPSS ver. 22, 
the correlation was analyzed by using Pearson 
Correlation. For determining the level of relations 
between variables, based on the correlation 
coefficient value which is the output of SPSS as below 
[14]: coefficient correlation 0.00 –< 02 = very weak 
relationship; coefficient correlation 0.2 –< 0.4 = weak 
relationship; coefficient correlation 0.4 –< 0.6 = 
enought relationship; coefficient correlation 0.6 – 0.8 = 
strong relationship; coefficient correlation 0.81 – 1.00 
= very strong relationship 
 
 
Results  
 
The sample of the experiments of this study 
included 35 peoples diagnosed with HIV. Based on 
Table 2 shows that the sex proportion of PLWHA is 19 
men, n = 54.3%, and women as many as 16 people, n 
= 45.7%. The proportion of education status for 
PLWHA 7 people (20%) is junior high school, 14 
people (40%) high school, and 14 people (40%) Strata 
1. The proportion of the marriage status of PLWHA is 
16 people (45.7%) married, and 19 people (54.3%) 
are unmarried. The mean age of PLWHA is 34.914 
with a standard of ± 6.391. From the results of the 
normality test data using Shapiro-Wilk, the value of p 
= 0.133 (p > 0.05. The mean length of diagnosed 
PLWHA is 26.543 with an SD ± 10.531. From the 
results of the normality test data using Shapiro-Wilk p-
value = 0.333 (p > 0.05). The mean length of getting 
ARV therapy for PLWHA is 25.143 with a standard of 
± 10.201. From the results of the normality test data 
using Shapiro-Wilk the value of p = 0.203 (p > 0.05). 
The mean CD4 level of PLWHA is 288.171 with the 
SD ± 88.955. From the results of the normality test of 
data using Shapiro-Wilk the value of p = 0.153 (p > 
0.05). 
Table 2: Socio-demographic Characteristics 
Characteristics mean ± SD 
 n (%) p 
N (%) P 
Age (years) 34.914 ± 6.391  0.133 
Duration of arv treatment (months) 25.143 ± 10.201  0.203 
Gender 
Man 
Women 
 
 
 
19 (54.3%) 
16 (45.7%) 
 
HIV clinical stadium 
Stage ii 
Stage iii 
  
18 (51.4 %) 
17 (54.3 %) 
 
Job-status 
Work 
Does not work 
  
16 (45.7 %) 
19 (54.3 %) 
 
Level of education 
Junior high school  
High school 
Pt 
  
7 (20 %) 
14 (40 %) 
14 (40 %) 
 
Long diagnosed (months) 26.543 ± 10.531  0.333 
Marital status 
Married 
Not married 
  
16 (45.7 %) 
19 (54.3 %) 
 
*Shapiro-Wilk Test. 
 
Based on Table 3, the average HADS-A score 
of PLWHA is 15.286, and the standard deviation is 
2.244. From the results of the data normality test 
using Shapiro-Wilk, the p-value = 0.221 (p > 0.05). 
Table 3: Average levels of HADS-A PLWHA 
Variable Average SD P 
Skor HADS-A PLWHA 15.286 ± 2.244 0.221 
*Shapiro-Wilk Test. 
 
Based on Table 4, the average HADS-D 
score of PLWHA is 15.286, and the standard deviation 
is 2.244. From the results of normality test data using 
Shapiro-Wilk, the value of p = 0.072 (p > 0.05). 
Table 4: Average levels of HADS-D PLWHA 
Variable Average SD P 
Skor HADS-D PLWHA 15.286 ± 2.244 0.072 
*Shapiro-Wilk Test. 
 
Table 5 shows that CD4 levels of PLWHA are 
with an average of 288.171 and the standard 
deviation is 88.955. From the results of the normality 
test of data using Shapiro-Wilk the value of p = 0.153 
(p > 0.05). 
Table 5: Average CD4 Levels of PLWHA 
Variable Average SB P 
CD4 PLWHA Level 288.171 ± 88.955 0.153 
*Shapiro-Wilk Test. 
 
Correlation Analysis 
The results of the Pearson Correlation test of 
HADS-A and CD4 levels obtained p < 0.001 (p < 0.05) 
and it was concluded that there was a correlation 
between HADS-A scores and CD4 levels. The 
strength of the relationship between HADS-A scores 
and CD4 levels was r = -0.592, indicating a negative 
correlation with the strength of moderate correlation (r 
= 0.4 -< 0.6) (Table 6). 
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Table 6: Correlation of HADS-A Scores and CD4 Levels of 
PLWHA 
 Level of CD4 
Score HADS-A r = -0.592 
p < 0.001 
n = 35 
*Pearson Correlation Test. 
 
The results of the Pearson Correlation test of 
HADS-D score and CD4 levels obtained p values < 0, 
001 (p < 0.05) and it was concluded that there was a 
correlation between HADS-D scores and CD4 levels. 
The strength of the relationship between the HADS-A 
score and CD4 level was -0.650, indicating a negative 
correlation with a strong correlation strength (r = 0.6- 
<0.8) (Table 7). 
Table 7: Correlation of HADS-D Scores and CD4 Levels of 
PLWHA 
 Level of CD4 
Score HADS-D r = -0.650 
p < 0.001 
n = 35 
*Pearson Correlation Test. 
 
 
 
Discussion 
 
On the demographic characteristics of the 
research, subjects showed that the average age of 
PLWHA was 34.914 years, with the standard 
deviation being 6.391. This result is in line with data 
from the Indonesian Ministry of Health Data and 
Information Center which reported the number of HIV 
infections according to age groups from 2010 to 
September 2014 in the age range of 25-49 years [17]. 
Report on the progress of HIV/AIDS & quarterly 
infectious social in 2017, reported the highest 
percentage of infections occurred in the age group 25-
49 years [18]. A study conducted by Getachew T et 
al., in 2015 found that the highest age range for 
PLWHA was in the age of 30-39 years [19]. The study 
conducted by Saragih J in 2008 at H. Adam Malik 
General Hospital Medan also found that the highest 
ODHA age range was at the age of 30-39 years [20]. 
The proportion of sex of PLWHA was 19 
people (54.3%) for men, and 16 people (45.7%) for 
women. Data from the Indonesian Ministry of Health's 
Data and Information Center, which reported the 
number of AIDS cases in Indonesia by sex from 1987 
to September 2014, was more prevalent in the male 
group (54%) or almost twice compared to the female 
group (29%) [17]. The proportion of education levels 
for PLWHA is 7 people (20%), Senior hight school as 
many as 14 people (40%) and S1 as many as 14 
people (40%). The proportion of occupational status of 
PLWHA is 19 people (54.3%) working and 16 people 
(45.7%) not working. The proportion of the marriage 
status of PLWHA is 16 people (45.7%) with marital 
status and 19 people (54.3%) with unmarried status. A 
study conducted by Saragih J in 2008 at H. Adam 
Malik General Hospital in Medan found slightly 
different results, namely the most educated PLHIV 
were high school (73%), followed by junior high school 
(14%), S1 (8%) and elementary school (5%), for the 
marriage status of PLWHA, the majority are married 
(51%), not married is (49%), the highest employment 
status is not working (62%), not working as much 
(36%) [20]. 
The proportion of HIV/AIDS clinical stadiums 
of PLWHA were 18 people (51.4%) in stage II, and 17 
people (48.6%) were in stage III. HIV/AIDS Stadium is 
determined based on WHO criteria by looking at the 
clinical condition of PLWHA [2], [3]. The average 
length of diagnosed PLWHA is 26.543 months with a 
standard of 10.531. The length of time diagnosed with 
HIV/AIDS affects the mental condition and CD4 levels 
of PLWHA. From a study conducted by Rachel 
Ramovha in 2012 it was said that the initial response 
from someone who just found out that he was 
suffering from HIV/AIDS will occur in various 
responses, such as feeling not believe in diagnosis, 
denial, anger, anxiety, feelings of depression, to the 
worst is the thought of suicide [21]. The average 
length of ARV treatment for PLWHA is 25.143 months 
with standards deviation 10.201. From a study 
conducted by Saurez N, and colleagues in 2017 in 
Mexico, said that anxiety symptoms and depression 
symptoms were associated with poor rates of ARV 
treatment in PLWHA, and also associated with poor 
virology control and lower CD4 cell counts [22]. 
The mean HADS-A score of PLWHA is 
15.286 and SD ± 2.244. This shows that PLWHA is in 
a moderate to severe anxiety condition, as indicated 
by the HADS-A score of 11-15 is moderate anxiety, 
and the HADS-A score is 16-21 is severe anxiety [15]. 
A study conducted by Monica N et al. in 2017 in Brazil 
anxiety symptoms were found as measured by the 
BAI measuring scale, getting results that were as 
much as 31.9% with mild anxiety, based on the BAI 
score of 11-19 [23]. 
The mean HADS-D score of PLWHA is 
15,286 and the sd ± 2,244. This shows that PLWHA is 
in moderate to severe depression, indicated by the 
value of the HADS-D score is 11-15 is moderate 
anxiety, and the HADS-D score is 16-21 is severe 
anxiety. 
In conclusion, from this study, it was found 
that there is a relationship between depression and 
anxiety symptom and CD4 level. There is a significant 
correlation between the HADS-A score and CD4 level 
with a correlation value of r = -0.592 indicating a 
negative correlation with a moderate correlation 
strength. There is a correlation between HADS-D 
scores and CD4 levels. The strength of the 
relationship between HADS-D scores and CD4 levels 
was r = -0.650 indicating a negative correlation with 
strong correlation strength. 
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